Showing results (21-30 of 1,681) with videos related to
Sort By:
Pageof 169
Biometrics|September 2, 2004
A semiparametric method for analyzing matched case-control family studies with a continuous outcome and proband samplingMolin Wang, John M Williamson, Susan RedlineThe International Journal of Biostatistics|November 1, 2024
Hypothesis testing for detecting outlier evaluatorsLi Xu, David M Zucker, Molin WangStatistics in Medicine|January 12, 2016
Quantifying risk over the life course - latency, age-related susceptibility, and other time-varying exposure metricsMolin Wang, Xiaomei Liao, Francine Laden, et al.The Journal of Pharmacology and Experimental Therapeutics|October 15, 2003
Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcuminPo-Yung Cheng, Molin Wang, Edward T MorganEpidemiology (Cambridge, Mass.)|April 17, 2024
Causal Selection of Covariates in Regression Calibration for Mismeasured Continuous ExposureWenze Tang, Donna Spiegelman, Xiaomei Liao, et al.Statistics in Medicine|February 4, 2026
Causal Covariate Selection for the Regression Calibration Method for Exposure Measurement Error Bias CorrectionWenze Tang, Donna Spiegelman, Yujie Wu, et al.Medicine|February 19, 2025
Construction of a risk prediction model to identify potential risk factors for the development of delirium after total hip arthroplastyYong-Chao ChengLifetime Data Analysis|August 6, 2017
The competing risks Cox model with auxiliary case covariates under weaker missing-at-random cause of failureDaniel Nevo, Reiko Nishihara, Shuji Ogino, et al.Statistical Methods in Medical Research|January 23, 2024
Comparison between inverse-probability weighting and multiple imputation in Cox model with missing failure subtypeFuyu Guo, Benjamin Langworthy, Shuji Ogino, et al.Breast Cancer Research and Treatment|August 30, 2011
Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100)David Cella, Molin Wang, Lynne Wagner, et al.Pageof 169